TLR9 and neoplasm: Plasmacytoid DC usually promote the anti-tumor responses via the Toll-like receptor 9 (TLR9) -dependent synthesis of interferon-α (IFN-α), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α).